Blog

[printfriendly]
  • Mar 11, 2015

    Research Update Neuropathy: Relief for Diabetics with Painful Conditions

    In 2013, we published a research study involving Phase II Hepatocyte Growth Factor (HCF) in Patients with Painful Diabetic Peripheral Neuropathy involving several study groups. The article below is an…
  • Feb 18, 2015

    Support Groups: Making Connections

    Support groups bring together people facing similar issues, whether that’s illness, relationship problems or major life changes. Members often share experiences and advice. It can be helpful to just talk…
  • Feb 18, 2015

    5 Tips for Maintaining Good Balance & Preventing Falls

    Falling is no laughing matter. Patients with Parkinson’s disease, peripheral neuropathy, lower extremity weakness, sensory loss, and substantial vision loss have a higher risk of falling. Good balance requires reliable…
  • You are unauthorized to view this page.

  • Oct 15, 2014

    Painful Diabetic Neuropathy

    Diabetes is a worldwide epidemic, and associated neuropathy is its most costly and disabling complication. Given the rising prevalence of painful diabetic neuropathy, it is increasingly important that we understand…
  • Jun 1, 2014

    Neuromodulatory Treatments for Chronic Pain: Efficacy and Mechanisms

    Chronic pain is common, and the available treatments do not provide adequate relief for most patients. Neuromodulatory interventions that modify brain processes underlying the experience of pain have the potential…
  • Jun 1, 2014

    A Skin Cream for Peripheral Neuropathy? Small Molecule May go a Long Way

    About half of people with diabetes develop peripheral neuropathy. While there are some treatments to reduce pain, there’s nothing that restores sensation. Gabriel Corfas, PhD, of the F.M. Kirby Neurobiology…
  • Jun 1, 2014

    Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    Chemotherapy-induced peripheral neuropathy (CIPN) is a common treatment-related adverse effect and affects long-term quality of life.1 It has the potential to result in chemotherapy dose reductions and/or early discontinuation.The purpose…